Efficacy and Safety of Tositumomab/Iodine-131 Tositumomab in the Expanded Access Study: Interim Report From Two Institutions
ByS. A. Gregory,M. Coleman,A. Ali,T. M. O'Brien,A. Subramanian,L. Kostakoglu,S. J. Goldsmith,N. Valente,J. P. Leonard
Published: | Updated:
Relapsed or refractory low-grade non-Hodgkin’s lymphoma (NHL) and transformed low-grade NHL are incurable diseases. Tositumomab/iodine-131 tositumomab (Bexxar) is a novel